In PAAD patients, cluster 3 patients were mainly enriched in squama cell subtypes that possessed activated hypoxia, inflammatory response, TGF-β signaling, and MYC pathway activation. The gene discussed is TGFB1; the disease is pancreatic adenocarcinoma.